EMMA ARSIC: Open Payments
NPI 1194316687 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 36 payments from 15 companies in 2025. Trend: 2023 $286 · 2024 $1,013 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $147 |
| Lundbeck LLC | 5 | $126 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| ABBVIE INC. | 3 | $87 |
| Neurocrine BioSciences, Inc. | 2 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Tris Pharma Inc | 2 | $43 |
Products named: REXULTI, ARISTADA, AUSTEDO XR, VRAYLAR, INGREZZA, CAPLYTA, Qelbree, SPRAVATO.
Industry payments across IL — which companies pay providers there.
